Antimicrobial resistance
ナビゲーションに移動
検索に移動
| Navigation Menu | 
|
| 展開するGeneral issues of Vaccine |
|---|
| 展開するGeneral issues of Tropical med. |
|---|
| 展開するGeneral issues of Travel med. |
|---|
| 展開するImmunology |
|---|
| 展開するEpi & Stats |
|---|
| 展開するVirus |
|---|
| 展開するCOVID-19 |
|---|
| 展開するBacteria |
|---|
| 展開するRickettsia |
|---|
| 展開するProtozoa |
|---|
| 展開するFungi |
|---|
| 展開するNematode (roundworm) |
|---|
| 展開するTrematode (fluke, distoma) |
|---|
| 展開するCestode (tapeworm) |
|---|
| 展開するMedical Zoology |
|---|
AMR Action Plan
- estimation of deaths by AMR of 10 mil. in 2050 without any action
- O'Neill Report in 2013
- in many developing countries no prescription system
- one health approach
National AMR Action Plan in Japan 2016
- public awareness and education
- surveillance and monitoring
- infection prevention and control
- appropriate use of antimicrobials
- research and development
- international cooperation
- goals for 2020
- 33% reduction of total antimicrobials
- 50% reduction of broad spectrum oral antibiotics
- 20% reduction of IV antimicrobials
- compared to 2013
- results
- 10.9%
